Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies.

导出 LinkOut

翻译打印收藏纠错

作者： George,Sakoulas ^[1] ; Paul B,Eckburg ^[2] ; Maria,Amodio-Groton ^[2] ; Amy,Manley ^[2] ; Evan,Tzanis ^[2] ; Anita F,Das ^[3] ; Robert,Noble ^[2] ; Paul C,McGovern ^[2]

作者单位： University of California, San Diego, California, USA. ^[1] Paratek Pharmaceuticals Inc., King of Prussia, Philadelphia, USA. ^[2] AD Stats Consulting, Guerneville, California, USA. ^[3]

关键词 acute bacterial skin and skin structure infections community-acquired pneumonia efficacy omadacycline secondary bacteremia

DOI 10.1093/ofid/ofab136

PMID 34160473

发布时间 2021-07-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Open forum infectious diseases

2021年8卷6期

ofab136页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies.

Open forum infectious diseases

相似文献

Open forum infectious diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies.

Open forum infectious diseases

相似文献

Open forum infectious diseases

相关期刊

检索历史清除